QuickView for GPI anchor binding (biogroup)

1. L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
2. Response of breast tumors treated with docetaxel-capecitabine (+/- trastuzumab)
3. L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
4. L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
5. Mesenchymal stem cells (MSC) during adipogenic differentiation (timecourse)

There were no matches for GPI anchor binding

1. Medical Complications in Familial and Multifactorial Chylomicronaemia Syndromes
2. The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemogl…
3. Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria®
4. A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Fede…